Evaluation of high dose atorvastatin therapy 24 hours before elective percutaneous coronary intervention on peri-PCI myocardial infarction
Background: Percutaneous coronary intervention (PCI) may been associated with high-er risk of cardiac events during this procedure. The goal of this study was to compare high dose atorvastatin therapy with low dose atorvastatin therapy 24 hours before PCI to a reduction in Peri- percutaneous coronar...
Main Authors: | Rahmani R, Nafasi L, Salary A, Meisami A, Abdollahi A |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2013-02-01
|
Series: | Tehran University Medical Journal |
Subjects: | |
Online Access: | http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-56&slc_lang=en&sid=1 |
Similar Items
-
Late onset rhabdomyolysis developing secondary to atorvastatin therapy in a coronary artery disease patient
by: Somak Kumar Das, et al.
Published: (2015-01-01) -
STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01) -
Effect of Very Early Atorvastatin Initiation for Acute Myocardial Infarction on Creatine Kinase release
by: Faris Abdul Kareem, et al.
Published: (2010-06-01) -
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
by: Kreutz RP, et al.
Published: (2016-06-01) -
The effect of lycopene on serum level of cardiac biomarkers in patients undergoing elective percutaneous coronary intervention: A randomized controlled clinical trial
by: Sedigheh Asgary, et al.
Published: (2021-02-01)